General Statement of Disclosure: CONSULTING FEES/HONORARIA: Novartis(MODEST) RESEARCH/RESEARCH GRANTS: Novartis Corporation(SIGNIFICANT), Novo Nordisk(SIGNIFICANT), Esperion(SIGNIFICANT), Gilead(SIGNIFICANT) View Full Disclosure